04/09/2026
Pleased to share a new Special Article published in the International Journal of Gynecology & Obstetrics, featuring Dr. Hema Divakar as one of the contributing authors.
📖 “Menopausal hormone therapy and comprehensive postmenopausal care in gynecologic cancer survivors: A position paper from the FIGO Committee on Women at Menopausal Age”
As more women survive gynecologic cancers, treatment-related menopause can have a significant impact on quality of life. This position paper brings together evidence and clinical considerations around menopausal hormone therapy, while emphasising personalised, evidence-based and equitable survivorship care.
Importantly, the paper recognises that menopause care cannot follow a one-size-fits-all approach. Decisions need to consider the type of cancer, tumour characteristics, individual risks and treatment history, with local vaginal and non-hormonal options remaining important when systemic hormone therapy is not appropriate.
🌍 The paper also highlights the disproportionate burden of gynecologic cancers in low- and middle-income countries, calling for context-specific and resource-aware approaches that make quality survivorship care more accessible.
A meaningful contribution towards ensuring that women receive not only longer lives after cancer, but better quality of life during survivorship.